EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Annals of the Rheumatic Diseases

Volumn 69, Issue 10, 2010, Pages 1744-1750

  Basu, Neil ^a   Watts, Richard ^b   Bajema, Ingeborg ^c   Baslund, Bo ^d   Bley, Thorsten ^e   Boers, Maarten ^f   Brogan, Paul ^g   Calabrese, Len ^h   Cid, Maria C ⁱ   Cohen Tervaert, Jan Willem ^j   Flores Suarez, Luis Felipe ^k   Fujimoto, Shouichi ^l   De Groot, Kirsten ^m   Guillevin, Loic ⁿ   Hatemi, Gulen ^o   Hauser, Thomas ^p   Jayne, David ^q   Jennette, Charles ^r   Kallenberg, Cees G M ^s   Kobayashi, Shigeto ^t   Little, Mark A ^u   Mahr, Alfred ⁿ   McLaren, John ^v   Merkel, Peter A ^w   Ozen, Seza ^x   Puechal, Xavier ^y   Rasmussen, Niels ^d   Salama, Alan ^z   Salvarani, Carlo ^aa   Savage, Caroline ^u   Scott, David G I ^ab   Segelmark, Mårten ^ac   Specks, Ulrich ^ad   Sunderköetter, Cord ^ae   Suzuki, Kazuo ^af   Tesar, Vladimir ^ag   Wiik, Allan ^ah   Yazici, Hasan ^o   Luqmani, Raashid ^ai   more..

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF FREIBURG   (Germany)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k National Institute of Respiratory Diseases   (Mexico)

^l UNIVERSITY OF MIYAZAKI   (Japan)

^m Klinikum Offenbach   (Germany)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

^o ISTANBUL UNIVERSITY   (Turkey)

^p Immunologie Zentrum Zurich   (Switzerland)

^q ADDENBROOKE S HOSPITAL   (United Kingdom)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

^s UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^t Juntendo University Hospital   (Japan)

^u UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^v NHS FIFE   (United Kingdom)

^w BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x HACETTEPE UNIVERSITY   (Turkey)

^y CENTRE HOSPITALIER DU MANS   (France)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa S MARIA NUOVA HOSPITAL   (Italy)

^ab NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^ac LUND UNIVERSITY   (Sweden)

^ad Mayo Clinc   (United States)

^ae UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^af CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ag CHARLES UNIVERSITY   (Czech Republic)

^ah STATENS SERUM INSTITUT   (Denmark)

^ai UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; BIOLOGICAL MARKER;

ARTICLE; BIOPSY; DISEASE CLASSIFICATION; DISEASE MARKER; HISTOLOGY; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; SYSTEMIC VASCULITIS; CLASSIFICATION; CONSENSUS DEVELOPMENT; DELPHI STUDY; EVIDENCE BASED MEDICINE; HUMAN; NOMENCLATURE; PROCEDURES;

BIOLOGICAL MARKERS; BIOPSY; DELPHI TECHNIQUE; EVIDENCE-BASED MEDICINE; HUMANS; SYSTEMIC VASCULITIS; TERMINOLOGY AS TOPIC;

EID: 77955735444     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.119032     Document Type: Article

References (97)

1. Watts RA, Scott DGI. Epidemiology of vasculitis. In Ball GV, Bridges L Eds. Vasculitis. 2nd edition. Oxford University Press: Oxford, 2008:7-22.
2. Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med 1967;43:8-14.
3. Adu D, Howie AJ, Scott DG, et al. Polyarteritis and the kidney. Q J Med 1987;62:221-37.
4. Harrison BJ, Symmons DP, Barrett EM, et al. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol 1998;25:2324-30.
5. Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990;33:1135-6.
6. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
7. Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990;33:1108-13.
8. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948;17:175-202.
9. Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
10. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
11. Csernok E, Ahlquist D, Ullrich S, et al. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 2002;41:1313-17.
12. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52:2926-35.
13. Guillevin L, Lhote F, Amouroux J, et al. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996;35:958-64. (Pubitemid 126719612)
14. Rao JK, Allen NB, Feussner JR, et al. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995;346:926-31.
15. Lane SE, Watts RA, Barker TH, et al. Evaluation of the sorensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology 2002;41:1138-41.
16. Sørensen SF, Slot O, Tvede N, et al. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 2000;59:478-82.
17. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.
18. Dougados M, Betteridge N, Burmester GR, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004;63:1172-6.
19. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1301-11.
20. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 2009;68:8-17.
21. Chu CT, Gray L, Goldstein LB, et al. Diagnosis of intracranial vasculitis: a multi-disciplinary approach. J Neuropathol Exp Neurol 1998;57:30-8. (Pubitemid 28057175)
22. Alrawi A, Trobe JD, Blaivas M, et al. Brain biopsy in primary angiitis of the central nervous system. Neurology 1999;53:858-60.
23. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
24. Hauer HA, Bajema IM, van Houwelingen HC, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002;61:80-9.
25. Niederkohr RD, Levin LA. Management of the patient with suspected temporal arteritis a decision-analytic approach. Ophthalmology 2005;112:744-56.
26. Jennings CR, Jones NS, Dugar J, et al. Wegener's granulomatosis - a review of diagnosis and treatment in 53 subjects. Rhinology 1998;36:188-91.
27. Del Buono EA, Flint A. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum Pathol 1991;22:107-10.
28. Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990;14:555-64. (Pubitemid 20172526)
29. Murray A, McGarry GW. The clinical value of septal perforation biopsy. Clin Otolaryngol Allied Sci 2000;25:107-9.
30. Maguchi S, Fukuda S, Takizawa M. Histological findings in biopsies from patients with cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis. Auris Nasus Larynx 2001;28 Suppl:S53-8. (Pubitemid 33713129)
31. Albert DA, Silverstein MD, Paunicka K, et al. The diagnosis of polyarteritis nodosa. II. Empirical verification of a decision analysis model. Arthritis Rheum 1988;31:1128-34.
32. Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 1988;31:1117-27.
33. Taylor-Gjevre R, Vo M, Shukla D, et al. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005;32:1279-82.
34. Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 1984;43:416-17.
35. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
36. Ray-Chaudhuri N, Kiné DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 2002;86:530-2.
37. Sharma NS, Ooi JL, McGarity BH, et al. The length of superficial temporal artery biopsies. ANZ J Surg 2007;77:437-9.
38. Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis 2006;65:826-8. (Pubitemid 43799187)
39. Chakrabarty A, Franks AJ. Temporal artery biopsy: is there any value in examining biopsies at multiple levels? J Clin Pathol 2000;53:131-6.
40. Hayreh SS, Podhajsky PA, Raman R, et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285-96.
41. Helander SD, De Castro FR, Gibson LE. Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis. Acta Derm Venereol 1995;75:125-9.
42. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9. (Pubitemid 15173133)
43. Choi HK, Liu S, Merkel PA, et al. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 2001;28:1584-90.
44. Fienberg R, Mark EJ, Goodman M, et al. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 1993;24:160-8.
45. Rao JK. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
46. Harris A, Chang G, Vadas M, et al. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis. J Clin Pathol 1999;52:670-6. (Pubitemid 29456903)
47. Stone JH, Talor M, Stebbing J, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000;13:424-34.
48. Pollock W, Dunster K, Rolland JM, et al. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase. Pathology 1999;31:38-43.
49. Chen M, Yu F, Zhang Y, et al. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005;68:2225-9. (Pubitemid 43117797)
50. Merkel PA, Polisson RP, Chang Y, et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126:866-73.
51. McLaren JS, Stimson RH, McRorie ER, et al. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM 2001;94:615-21.
52. Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008;14:1088-96.
53. Hauschild S, Schmitt WH, Csernok E, et al. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993;336:245-51.
54. Guillevin L, Lhote F, Brauner M, et al. Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome: indications for the diagnosis of microscopic polyangiitis. Ann Med Interne (Paris) 1995;146:548-50.
55. Baranger TA, Audrain MA, Testa A, et al. Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification? Autoimmunity 1995;20:33-7.
56. Cats HA, Tervaert JW, van Wijk R, et al. Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica. Adv Exp Med Biol 1993;336:363-6.
57. Guzman J, Fung M, Petty RE. Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr 1994;124:917-20. (Pubitemid 24184017)
58. Waldendorf M, Schneider M. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Adv Exp Med Biol 1993;336:381-4.
59. Charles PJ, Maini RN. Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritis. Adv Exp Med Biol 1993;336:367-70.
60. Savige JA, Chang L, Crowe SM. Anti-neutrophil cytoplasm antibodies in HIV infection. Adv Exp Med Biol 1993;336:349-52.
61. Flores-Suárez LF, Cabiedes J, Villa AR, et al. Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford) 2003;42:223-9. (Pubitemid 36305606)
62. Pradhan VD, Badakere SS, Ghosh K, et al. Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J Med Sci 2004;58:283-8.
63. Mulder AH, Broekroelofs J, Horst G, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994;95:490-7.
64. Halbwachs-Mecarelli L, Nusbaum P, Noël LH, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79-84.
65. Olaf W, Kimberly AR, Augustine SL, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arth Rheum 2004;50:2954-65.
66. Gunton JE, Stiel J, Clifton-Bligh P, et al. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrin 2000;142:587-90.
67. Mege JL, Escallier JC, Capo C, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) and infection. Adv Exp Med Biol 1993;336:353-6.
68. Mandl LA, Solomon DH, Smith EL, et al. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy? Arch Intern Med 2002;162:1509-14.
69. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 1988;12:964-72.
70. Sharma BK, Jain S, Suri S, et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol 1996;54 Suppl:S141-7.
71. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 1998;209:103-9.
72. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breathhold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging 2000;11:481-7.
73. Yamada I, Numano F, Suzuki S. Takayasu arteritis: evaluation with MR imaging. Radiology 1993;188:89-94.
74. Maeda H, Handa N, Matsumoto M, et al. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: "macaroni sign" as an indicator of the disease. Ultrasound Med Biol 1991;17:695-701.
75. Choe YH, Kim DK, Koh EM, et al. Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 1999;10:751-7.
76. Miller DL, Reinig JW, Volkman DJ. Vascular imaging with MRI: inadequacy in Takayasu's arteritis compared with angiography. AJR Am J Roentgenol 1986;146:949-54.
77. Webb M, Chambers A, AL-Nahhas A, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004;31:627-34.
78. Walter MA, Melzer RA, Schindler C, et al. The value of (18F)FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674-81.
79. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with ((18) F)FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730-6.
80. Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 2006;8:R116.
81. Bley TA, Weiben O, Uhl M, et al. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 2005;52:2470-7.
82. Bley TA, Wieben O, Uhl M, et al. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 2005;184:283-7.
83. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004;43:241-2.
84. Karassa FB, Matsagas MI, Schmidt WA, et al. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005;142:359-69.
85. Hekali P, Kajander H, Pajari R, et al. Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol 1991;32:143-8.
86. Lightfoot RW Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
87. Travers RL, Allison DJ, Brettle RP, et al. Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum 1979;8:184-99.
88. Muhle C, Reinhold-Keller E, Richter C, et al. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis. Eur Radiol 1997;7:566-70.
89. Simmons JT, Leavitt R, Kornblut AD, et al. CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis. Ear Nose Throat J 1987;66:134-40.
90. Kadkhodayan Y, Alreshaid A, Moran CJ, et al. Primary angiitis of the central nervous system at conventional angiography. Radiology 2004;233:878-82.
91. Salvarani C, Brown RD Jr, Calamia KT, et al. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 2008;87:264-71.
92. Woywodt A, Haubitz M, Haller H, et al. Wegener's granulomatosis. Lancet 2006;367:1362-6.
93. Panush RS, Wallace DJ, Dorff RE, et al. Retraction of the suggestion to use the term "Reiter's syndrome" sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 2007;56:693-4.
94. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84:313-22. (Pubitemid 41368484)
95. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74.
96. García-Porrúa C, González-Gay MA. Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schönlein purpura in adults. Semin Arthritis Rheum 1999;28:404-12.
97. Phillips WG, Marsden JR. Adult Kawasaki syndrome. Br J Dermatol 1993;129:330-3.